Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea.
-
CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea.
-
The Global Virus Network underscores the continued threat of H5N1 and calls for sustained global vigilance, surveillance, and preparedness.
-
Measles is resurging at a scale not seen in decades.
-
MinervaX Strengthens Executive Leadership Team with Two Strategic Appointments as it Advances its Maternal GBS Vaccine Towards Pivotal Trial Initiation
-
Early findings of SARS-CoV-2 Variant BA.3.2 (“Cicada”), show no evidence of increased severity or widespread transmission
-
Micron Biomedical makes the Most Innovative Companies List in recognition of clinical, financial and other progress toward needle-free vaccines and drugs.
-
Austin, TX, USA, March 10, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Viral Vaccine Cell Culture Media Market Size, Trends and Insights By Cell...
-
Austin, TX, USA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Adeno Associated Virus Vector Manufacturing Market Size, Trends and Insights By...
-
Measles is one of the most contagious viral diseases known and can be lethal, particularly in unvaccinated children. Yet, it remains entirely preventable.